U.S. drugmakers have unrealistic expectations of the cost savings they can get by manufacturing in India, says an Indian pharmaceutical exec. The playing field is now level between the two countries, given that equipment and regulatory compliance costs are the same and India's top scientists are earning $90,000 per year..................
Consultoria especializada em GMP/BPF para indústrias voltadas a Ciências da Vida!
segunda-feira, 26 de setembro de 2011
Manufacturing cost gap closing among U.S., India, China - FiercePharma Manufacturing
Manufacturing cost gap closing among U.S., India, China - FiercePharma Manufacturing:
U.S. drugmakers have unrealistic expectations of the cost savings they can get by manufacturing in India, says an Indian pharmaceutical exec. The playing field is now level between the two countries, given that equipment and regulatory compliance costs are the same and India's top scientists are earning $90,000 per year..................
U.S. drugmakers have unrealistic expectations of the cost savings they can get by manufacturing in India, says an Indian pharmaceutical exec. The playing field is now level between the two countries, given that equipment and regulatory compliance costs are the same and India's top scientists are earning $90,000 per year..................
Assinar:
Postar comentários (Atom)
Nenhum comentário:
Postar um comentário